Top Markets
Coin of the day
Heyu Biological Technology Corporation Heyu Biological Technology Corporation

Heyu Biological Technology Corporation

HYBT
Rangering i aksjer #27957
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on... Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease. The company, incorporated in 1987 and headquartered in Xiamen, People's Republic of China, was formerly known as Pacific WebWorks, Inc., before adopting its current name, Heyu Biological Technology Corporation, in June 2018.
Aksjekurs
$0.2853
Sist synkronisert: 2023-12-15
Markedsverdi
$29.46M
Endring (1 dag)
4.70%
Endring (1 år)
0.00%
Land
CN
Handel Heyu Biological Technology Corporation (HYBT)

Kategori

Driftsmargin for Heyu Biological Technology Corporation (HYBT)
Driftsmargin per 2026 TTM: 0.00%
Ifølge Heyu Biological Technology Corporation sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 0.00%. Ved slutten av 2026 hadde selskapet en driftsmargin på 0.00%.
Historikk for driftsmargin for Heyu Biological Technology Corporation fra 2026 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
Ikke nok data for de angitte datoene.
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
17.03% -
US
22.03% -
US
17.86% -
IE
21.46% -
US
28.09% -
US
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.